Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]

. 2023 May ; 83 (5) : e140-e141. [epub] 20230224

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium print-electronic

Typ dokumentu tisková chyba

Perzistentní odkaz   https://www.medvik.cz/link/pmid36841687
Odkazy

PubMed 36841687
DOI 10.1016/j.eururo.2023.02.007
PII: S0302-2838(23)02579-4
Knihovny.cz E-zdroje

Department of Health Evidence Radboud University Medical Center Nijmegen The Netherlands

Department of Pathology Caritas St Josef Medical Center University of Regensburg Regensburg Germany

Department of Pathology Città della Salute e della Scienza University of Torino School of Medicine Torino Italy

Department of Pathology Comprehensive Cancer Center Medical University Vienna Vienna General Hospital Vienna Austria

Department of Pathology Fundacio Puigvert Universitat Autònoma de Barcelona Barcelona Spain

Department of Pathology Fundación Instituto Valenciano de Oncología Valencia Spain

Department of Pathology General Teaching Hospital and 1st Faculty of Medicine Charles University Praha Prague Czech Republic

Department of Pathology Hospital Universitario Fundación Alcorcón Madrid Spain

Department of Pathology Medical University of Graz Graz Austria

Department of Pathology Pitié Salpétrière Hospital AP HP Pierre et Marie Curie Medical School Sorbonne University Paris France

Department of Pathology Radboud University Medical Center Nijmegen The Netherlands

Department of Pathology Royal Free London NHS Foundation Trust Royal Free Hospital London UK

Department of Pathology Teaching Hospital Motol and 2nd Faculty of Medicine Charles University Praha Prague Czech Republic

Department of Surgical Oncology Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

Department of Surgical Oncology University Health Network Princess Margaret Cancer Center University of Toronto Toronto Canada

Department of Urology Amsterdam University Medical Center Vrije Universiteit Amsterdam The Netherlands

Department of Urology Amsterdam University Medical Center Vrije Universiteit Amsterdam The Netherlands; Department of Surgical Oncology Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

Department of Urology Caritas St Josef Medical Center University of Regensburg Regensburg Germany

Department of Urology Città della Salute e della Scienza University of Torino School of Medicine Torino Italy

Department of Urology Comprehensive Cancer Center Medical University Vienna Vienna General Hospital Vienna Austria

Department of Urology Fundacio Puigvert Universitat Autònoma de Barcelona Barcelona Spain

Department of Urology Fundacio Puigvert Universitat Autònoma de Barcelona Barcelona Spain; Department of Urology Città della Salute e della Scienza University of Torino School of Medicine Torino Italy

Department of Urology Fundación Instituto Valenciano de Oncología Valencia Spain

Department of Urology General Teaching Hospital and 1st Faculty of Medicine Charles University Praha Prague Czech Republic

Department of Urology Hospital Universitario Fundación Alcorcón Madrid Spain

Department of Urology Medical University of Graz Graz Austria

Department of Urology Pitié Salpétrière Hospital AP HP Sorbonne University Paris France

Department of Urology Radboud University Medical Center Nijmegen The Netherlands

Department of Urology Royal Free London NHS Foundation Trust Royal Free Hospital London UK

Department of Urology Teaching Hospital Motol and 2nd Faculty of Medicine Charles University Praha Prague Czech Republic

Department of Urology Tenon Hospital AP HP Sorbonne University Paris France

Department of Urology The Stokes Centre for Urology Royal Surrey Hospital Guildford UK

European Association of Urology Guidelines Office Arnhem The Netherlands

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Pathology Tenon Hospital AP HP Sorbonne University Paris France

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Caritas St Josef Medical Center University of Regensburg Regensburg Germany

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Caritas St Josef Medical Center University of Regensburg Regensburg Germany; Department of Surgical Oncology University Health Network Princess Margaret Cancer Center University of Toronto Toronto Canada

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Città della Salute e della Scienza University of Torino School of Medicine Torino Italy

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Fundacio Puigvert Universitat Autònoma de Barcelona Barcelona Spain

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Fundación Instituto Valenciano de Oncología Valencia Spain

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology General Teaching Hospital and 1st Faculty of Medicine Charles University Praha Prague Czech Republic

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Hospital Universitario Fundación Alcorcón Madrid Spain

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Medical University of Graz Graz Austria

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Pitié Salpétrière Hospital AP HP Sorbonne University Paris France

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Radboud University Medical Center Nijmegen The Netherlands

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Royal Free London NHS Foundation Trust Royal Free Hospital London UK

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology Teaching Hospital Motol and 2nd Faculty of Medicine Charles University Praha Prague Czech Republic; Department of Urology Comprehensive Cancer Center Medical University Vienna Vienna General Hospital Vienna Austria

European Association of Urology Non Muscle Invasive Bladder Cancer Guidelines Panel Arnhem The Netherlands; Department of Urology The Stokes Centre for Urology Royal Surrey Hospital Guildford UK

Laboratory Medicine Program University Health Network Princess Margaret Cancer Center University of Toronto Toronto Canada

Erratum pro

PubMed

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace